We see consolidation and market expansion in medical devices and our spine niche for the next 5 years as companies innovate to satisfy the demand from a growing aging population. Large players will respond to growth pressures and to competition from new innovations particularly in the areas of motion preservation and biologics through consolidation as evidenced by multiple recent acquisitions. This creates a favorable private equity platform for companies like us to capitalize on growth and buyout opportunities with near term exits.

Download Investor Letter Here

Name *